C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
01/2007
01/02/2007	CA2218892C Diaromatic propynyl or dienyl compounds
12/2006
12/30/2006	CA2551085A1 Ionization modifier for mass spectrometry
12/28/2006	WO2006138673A2 Synthetic processes for the preparation of aminocyclohexyl ether compounds
12/28/2006	WO2006137509A1 Cyclic amine derivative containing ppar regulator
12/28/2006	WO2006136924A1 Histamine-3 receptor antagonists
12/28/2006	WO2006136305A1 SUBSTITUTED PYRR0LIDIN-2-0NES , PIPERIDIN-2-0NES AND ISOTHIAZOLIDINE-1, 1-DIOXIDES, THEIR USE AS KVl .5 POTASSIUM CHANNEL BLOCKERS AND PHARMACEUTICAL PREPARATIONS COMPRISING THEM
12/28/2006	WO2006135973A1 Small molecule glycosaminoglycan mimetics
12/28/2006	WO2006098918B1 Substituted gamma lactams as therapeutic agents
12/28/2006	WO2006020664A3 Ammonolysis process for the preparation of intermediates for dpp iv inhibitors
12/28/2006	WO2006009789A3 Aryl-substituted piperazine derivatives
12/28/2006	US20060293380 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
12/28/2006	DE102005028845A1 New substituted pyrrolidin-2-ones, piperidin-2-ones and isothiazolidine-1,1-dioxides useful for treating e.g. dementia, Alzheimer's disease, Parkinson's disease, Huntington's disease, breast cancer and heart failure
12/28/2006	CA2613253A1 Combination comprising amino alcohol derivatives as immunosuppressants
12/28/2006	CA2612375A1 Synthetic processes for the preparation of aminocyclohexyl ether compounds
12/28/2006	CA2612338A1 Sphingosine kinase inhibitors
12/28/2006	CA2610326A1 Substituted pyrr0lidin-2-0nes , piperidin-2-0nes and isothiazolidine-1, 1-dioxides, their use as kv1.5 potassium channel blockers and pharmaceutical preparations comprising them
12/27/2006	EP1736465A1 Aniline derivatives
12/27/2006	EP1735307A1 Inhibitors of iap
12/27/2006	EP1735279A1 Prolinyl derivates for treating thrombosis
12/27/2006	EP1735278A1 Histamine h3 receptor agents, preparation and therapeutic uses
12/27/2006	EP1735270A1 Diamino alcohols and their use as renin inhibitors
12/27/2006	EP1734942A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
12/27/2006	EP1633708B1 Process for the preparation of n-alkyl-pyrrolidones
12/27/2006	EP1480961B1 Glutaminyl based dpiv inhibitors
12/27/2006	EP1404687B1 Fluorous triphase and other multiphase systems
12/27/2006	EP1149118B1 Method of producing derivatized polymers
12/27/2006	EP1021410B1 Prostaglandin agonists and their use to treat bone disorders
12/27/2006	CN1886421A Hemiasterlin derivatives and uses thereof
12/27/2006	CN1886391A Tetronic and tetramic acids as inhibitors of beta-secrease
12/27/2006	CN1886370A N-acyl-n -benzyl-alkylendiamino derivatives
12/27/2006	CN1291975C New mandelic acid derivatives and their use as thrombase inhibitors
12/27/2006	CN1291714C Application of phenchlobenpyrrone
12/26/2006	US7153978 Method for purifying N-methyl-2-pyrrolidone
12/26/2006	US7153889 Alzheimer's disease; antihistamines; attention deficit disorders; hyperactivity; bipolar disorders; cognition activators; psychological disorders; anticancer agents; antidepressants; antiepileptic agents; gastrointestinal disorders ; analgesics
12/26/2006	US7153883 Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds
12/26/2006	US7153881 Compounds acting as melanocortin receptor ligands
12/26/2006	US7153880 Substituted diphenyl heterocycles useful for treating HCV infection
12/21/2006	WO2006135860A1 Sulfonamide compounds and uses thereof
12/21/2006	WO2006135705A1 Process for producing cyano substituted arene boranes and compounds
12/21/2006	WO2006134955A1 1, 2-di(cyclic group)substituted benzene derivative
12/21/2006	WO2006134481A1 Inhibitors of 11-beta hydroxysteroid dehydrogenase type 1
12/21/2006	WO2006134385A2 Anti-inflammatory agents
12/21/2006	WO2006134384A1 Anti-inflammatory agents
12/21/2006	WO2006134379A1 Trityl derivatives for enhancing mass spectrometry
12/21/2006	WO2006134341A1 Therapeutic agents
12/21/2006	WO2006110783A3 Process for making (s)-pregabalin
12/21/2006	WO2006102007A3 Methods for synthesizing alkylated and alkenylated quinone derivatives
12/21/2006	WO2006087548A3 Pyrrole derivatives as dna gyrase and topoisomerase inhibitors
12/21/2006	WO2006041831A3 Cyclic β-amino acid derivatives as factor xa inhibitors
12/21/2006	WO2005118538A3 Arylsulfonamides and uses as hydroxysteroid dehydrogenase
12/21/2006	WO2005072376A3 Anionic-sweetener-based ionic liquids and methods of use thereof
12/21/2006	WO2005032468A3 Monocyclic and bicyclic lactams as factor xa inhibitors
12/21/2006	US20060287540 Method for preparing perfluorocarbon-substituted methanols
12/21/2006	US20060287539 Chemical intermediates for production of sibutramine
12/21/2006	US20060287538 Process for the preparation of amorphous calcium salt of atorvastatin
12/21/2006	US20060287529 Solid phase synthesis of antitumoral compounds
12/21/2006	US20060287369 Diarylmethyl and related compounds
12/21/2006	US20060287362 Organic compounds
12/21/2006	US20060287298 Pharmaceutical for treatment of neurological and neuropsychiatric disorders
12/21/2006	US20060287293 1-(4-{ethyl-[2-(4-methanesulfonylphenyl)-1-methylethyl]amino}butyl)-4-methanesulfonyl-[1,4]diazepan-2-one; repiratory system disorders: asthma and chronic obstructive pulmonary disease; nervous system, muscular,urogenital, gastrointestinal disorders; antiallergens; side effect reduction
12/21/2006	US20060286673 Amino acid or peptide in sample with labels to form carbamate and isotopes
12/21/2006	US20060286065 Useful in extending the in vivo circulating life of biologically active materials; bicine linker allows for the manipulation of the hydrolysis rate of the prodrug, thereby releasing the native entities at various rates in vivo as well as in vitro
12/21/2006	DE19843489B4 Benzoylguanidin-Abkömmlinge mit vorteilhaften Eigenschaften, Verfahren zu ihrer Herstellung und ihre Verwendung bei der Herstellung von Arzneimitteln, sowie diese enthaltende pharmazeutische Zubereitung Benzoylguanidine-derivatives having advantageous properties, to processes for their preparation and their use in the manufacture of medicinal products and pharmaceutical preparation containing them
12/21/2006	CA2612298A1 Anti-inflammatory agents
12/21/2006	CA2612217A1 Anti-inflammatory agents
12/21/2006	CA2611493A1 Sulfonamide compounds and uses thereof
12/21/2006	CA2611376A1 Therapeutic agents
12/21/2006	CA2607054A1 1, 2-di(cyclic group)substituted benzene derivative
12/20/2006	EP1734034A2 Carboxylic acid salts of beta-alanine esters or -amides
12/20/2006	EP1733724A1 Amino alcohol compound
12/20/2006	EP1732971A1 Process for the preparation of activated polyethylene glycols
12/20/2006	EP1732930A2 2,4,6-phenylsubstituted cyclic ketoenoles
12/20/2006	EP1732918A1 Novel pyrrolidine-3,4-dicarboxamide derivatives
12/20/2006	EP1732886A1 Polymorphs of atorvastatin tert.-butylester and use as intermediates for the preparation of atorvastatin
12/20/2006	EP1732885A1 Lactams as conformationally constrained peptidomimetic inhibitors
12/20/2006	EP1732884A1 Sulphonamide derivatives
12/20/2006	EP1732882A1 Non-glycosylated/non-glycosidic/non-peptidic small molecule psgl-1 mimetics for the treatment of inflammatory disorders
12/20/2006	EP1456171B1 Substituted cyclohexane derivatives
12/20/2006	EP1401809B1 Tryptase inhibitors
12/20/2006	EP1288198B1 Process for the production of sulfonic esters
12/20/2006	EP1263729B1 Azacyclic compounds for use in the treatment of serotonin related diseases
12/20/2006	EP1188745B1 Heterocyclic dicarboxylic acid diamide derivatives, agricultural/horticultural insecticides and method of using the same
12/20/2006	CN1882695A Enzymatic synthesis of enatiopure intermediates by means of cholesterolesterase from yeasts
12/20/2006	CN1882577A 喹唑啉衍生物 Quinazoline derivatives
12/20/2006	CN1882571A Pyrrolderivate
12/20/2006	CN1882536A 3-aminopyrrolidone derivatives
12/20/2006	CN1882535A Process for preparing 2-oxo-1-pyrrolidine derivatives
12/20/2006	CN1882534A Derivatives of n-[phenyl(pyrrolidine-2-yl)methyl]benzamide and n-[(azepan-2-yl)phenylmethyl]benzamide, preparation method thereof and application of same in therapeutics
12/20/2006	CN1882528A Organic compounds
12/20/2006	CN1882332A Dual alanyl aminopeptidase and dipeptidyl peptidase iv inhibitors for functionally influencing different cells and for treating immunological, inflammatory, neuronal and other diseases
12/20/2006	CN1880303A substituted pyrrolidone synthesized ion liquid and its synthesis method
12/20/2006	CN1880293A C2 phenyl-substituted cyclic keto-enols used as pesticides and herbicides
12/20/2006	CN1290844C Dihydro Indolinone derivatives used as protein kinase inhibitor
12/19/2006	US7151183 Processes for preparing amorphous atorvastatin hemi-calcium
12/19/2006	US7151175 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same
12/19/2006	US7151118 N-(6-Methyl-4'-{[3-(4-methylpiperazin-1-yl)propylamino]carbonyl}-1,1'-biphenyl-3-yl)-2-pyrrolidin-1-ylisonicotinamide; enzyme inhibitors for the treatment of certain diseases and conditions; chemical synthesis
12/19/2006	US7151115 Diphenylmethyl compounds useful as muscarinic receptor antagonists
12/19/2006	US7151111 Amine oxidase inhibitor; Alzheimer's disease
12/19/2006	CA2264979C Dicyclic-aromatic compounds and their application in human and veterinary medicine, as well as in cosmetics
12/14/2006	WO2006133326A1 Inhibitors of hcv replication

1 ... 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 ... 404